POST Online Media Lite Edition


Turning Point Therapeutics appoints Steve Sabus as CCO

Christian Fernsby |
San Diego, Ca., USA - Turning Point Therapeutics, a clinical-stage precision oncology company, announcedrnthe appointment of Steve Sabus as chief commercial officer, effective as of May 31, 2022.

Article continues below

Prior to Turning Point, Mr. Sabus spent 15 years in roles with increasing levels of sales responsibility at Astellas Pharma, most recently serving as the Head of Oncology leading a group of over 300 team members.

Earlier in his tenure, he headed the Astellas $2 billion U.S. Medical Specialties business unit, and was the General Manager of Astellas Canada,.